Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Loeb

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Cancer Treatment and Research|March 10, 2010
Is there a role for immunotherapy in osteosarcoma?David M Loeb
Clinical Advances in Hematology & Oncology : H&O|January 19, 2012
Targeted treatment in sarcoma patientsDavid M Loeb
Cell Cycle (Georgetown, Tex.)|June 9, 2006
WT1 influences apoptosis through transcriptional regulation of Bcl-2 family membersDavid M Loeb
International Journal of Hematology|September 7, 2002
The role of WT1 in oncogenesis: tumor suppressor or oncogene?David M Loeb, Saraswati Sukumar
Expert Reviews in Molecular Medicine|May 26, 2007
The role of the Wilms tumour gene (WT1) in normal and malignant haematopoiesisSuzie Ariyaratana, David M Loeb
Plos One|March 21, 2015
Hypoxia-sensitive epigenetic regulation of an antisense-oriented lncRNA controls WT1 expression in myeloid leukemia cellsGregory McCarty, David M Loeb
Human Vaccines & Immunotherapeutics|June 29, 2026
Immunotherapy in pediatric bone sarcomas: Current progress and future directionsRachel Weil, David M Loeb
Oncology (Williston Park, N.Y.)|August 31, 2002
What is the optimal therapy for childhood AML?David M Loeb, Robert J Arceci
The New England Journal of Medicine|April 4, 2003
Images in clinical medicine. Tumor pseudosyncytiaeGregory J Kato, David M Loeb
Clinical & Experimental Pharmacology|February 10, 2015
Beyond Palliation: Therapeutic Applications of <sup>153</sup>Samarium-EDTMPBreelyn A Wilky, David M Loeb
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Cancer Treatment and Research|March 10, 2010
Is there a role for immunotherapy in osteosarcoma?David M Loeb
Clinical Advances in Hematology & Oncology : H&O|January 19, 2012
Targeted treatment in sarcoma patientsDavid M Loeb
Cell Cycle (Georgetown, Tex.)|June 9, 2006
WT1 influences apoptosis through transcriptional regulation of Bcl-2 family membersDavid M Loeb
International Journal of Hematology|September 7, 2002
The role of WT1 in oncogenesis: tumor suppressor or oncogene?David M Loeb, Saraswati Sukumar
Expert Reviews in Molecular Medicine|May 26, 2007
The role of the Wilms tumour gene (WT1) in normal and malignant haematopoiesisSuzie Ariyaratana, David M Loeb
Plos One|March 21, 2015
Hypoxia-sensitive epigenetic regulation of an antisense-oriented lncRNA controls WT1 expression in myeloid leukemia cellsGregory McCarty, David M Loeb
Human Vaccines & Immunotherapeutics|June 29, 2026
Immunotherapy in pediatric bone sarcomas: Current progress and future directionsRachel Weil, David M Loeb
Oncology (Williston Park, N.Y.)|August 31, 2002
What is the optimal therapy for childhood AML?David M Loeb, Robert J Arceci
The New England Journal of Medicine|April 4, 2003
Images in clinical medicine. Tumor pseudosyncytiaeGregory J Kato, David M Loeb
Clinical & Experimental Pharmacology|February 10, 2015
Beyond Palliation: Therapeutic Applications of <sup>153</sup>Samarium-EDTMPBreelyn A Wilky, David M Loeb
Pageof 12